Loading...
•
Mar 31, 2022
Twist Bioscience Q2 2022 Earnings Report
Twist Bioscience achieved record revenue and order growth.
Key Takeaways
Twist Bioscience reported record revenue of $48.1 million for the second quarter of fiscal year 2022, a 54% increase compared to the previous year. Orders also increased by 32% to $55.0 million. Twist Biopharma added 5 new partnerships and 15 programs. The company is focused on managing cash burn and expects adjusted EBITDA break even for the core business upon reaching $300 million in revenue for synbio and NGS.
Record revenue of $48.1M in 2QFY22, a 54% increase year-over-year.
Orders increased 32% in 2QFY22 to $55.0M compared to the previous year.
Twist Biopharma added 5 new partnerships and 15 programs.
Twist is debugging its integrated CMOS chip for production capacity for data storage solutions.